Turing Pharmaceuticals

Turing's notoriety from 5,000% price hike on Daraprim demonstrates how drug pricing can trigger regulatory backlash. Martin Shkreli's $13.50-to-$750 overnight price increase made him 'most hated man in America' and invited scrutiny that eventually sent him to prison (for unrelated securities fraud). Like an organism whose aggressive behavior attracts predator attention, Shkreli's arrogance brought regulatory focus.